Healthcare >> Sector Roundtables >> September 20, 1999

Roundtable Forum: Medical Technology: Small Cap Stocks

ROBERT C. FAULKNER is a Senior Medical Device Analyst with Hambrecht & Quist. Previously, he was associated with Warburg Dillon Read, The Wilkerson Group and SmithKline Beecham. Mr. Faulkner earned his Bachelor's degree from Harvard University and an M.B.A. from the Tuck School of Business Administration at Dartmouth College. Profile
MICHAEL G. MULLEN, is an Independent Analyst and was formerly a Managing Director with S.G. Cowen Securities and previously associated with Banc One Asset Management. He earned his Bachelor's degree from Fordham University and his M.B.A. from Indiana University. A Chartered Financial Analyst, Mr. Mullen is a member of the Boston Securities Analyst Society and a Board member of the Indiana University Investment Management Academy. Profile
FREDERICK A. WISE, CFA, is a Managing Director at Bear, Stearns & Co., covering the medical supplies and devices industry. Mr. Wise is a six-year member of the Institutional Investor All America Research Team. In 1999 he was ranked number two and in 2000 he was ranked number three. He was named to the 2000 Wall Street Journal All-Star Analysts Survey for earnings forecasting. He was also ranked number four by The Reuters Survey 2000. Mr. Wise has a unique valuation approach, and has accurately anticipated the underperformance of stocks, as well as the performance of the industry in recent years. Prior to joining Bear Stearns, he was an Analyst at Kidder Peabody & Co. and Forbes, Inc. Mr. Wise received an MA and a BA from the Manhattan School of Music. Profile
TWST: Let's start by establishing the parameters of what constitutes

small capitalization or, small to medium capitalization, medical

technology stocks. Michael?

Mr. Mullen: I have generally